Perineal Massage in Women With Gynecological Cancer
Oncological Perineal Massage in Vaginal Stenosis and Dyspareunia in Women With Gynecological Cancer
University of Alcala
35 participants
May 31, 2024
INTERVENTIONAL
Conditions
Summary
The high incidence of gynecological cancers, together with dyspareunia and vaginal stenosis, some of its most frequent sequelae, create the need to continue studying and researching oncological physiotherapy techniques that treat and prevent these sequelae, in order to preserve and/or improve the quality of life of cancer patients. Therefore, through this study, we sought to verify the effectiveness of oncological perineal massage to treat pain during sexual intercourse and vaginal stenosis. The objective of this study will be to demonstrate the effectiveness of a treatment that will consist of a health education session related to the pelvic floor and the consequences related to cancer along with ten sessions of oncological perineal massage that will be carried out for fifty minutes, once a week.
Eligibility
Inclusion Criteria4
- Women between 18 and 52 years old
- Oncology patients with a diagnosis of dyspareunia and vaginal stenosis related to treatments.
- Patients with QT/RT/BT treatment who have a diagnosis of dyspareunia and vaginal stenosis.
- Patients on hormonal suppressive treatment with a diagnosis of dyspareunia and vaginal stenosis.
Exclusion Criteria5
- Patients who do not accept intracavitary treatment.
- Patients with abdominopelvic surgical treatment prior to oncological process.
- Patients with a diagnosis of dyspareunia prior to cancer.
- Patients with vaginal narrowing prior to cancer.
- Patients with menopause at the time of cancer diagnosis
Interventions
The technique will be applied for approximately twenty minutes and will be carried out as follows: the vaginal dilator is introduced progressively using crescent-shaped movements. Once the dilator is fully inserted, movements will be made from bottom to top and from one side to the other, and then continue with the crescent-shaped movements.
The treatment will consist of the use of vaginal dilators according to the gold standard proposed in the literature. It will consist of introducing the same dilators as for the experimental group, with the same time schedule, but without massage, only introducing the dilator and keeping it in the vagina for 20 minutes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06432998